Azenta, Inc. operates primarily through its Sample Management Solutions and Multiomics segments. The Sample Management Solutions division provides automated ultra-cold storage systems, cryogenic equipment, consumables, and sample repository services that ensure the integrity of biological and chemical compounds. The Multiomics segment offers genomic analysis, gene sequencing, and gene synthesis services to support drug discovery and clinical research. Additionally, its B Medical Systems business manufactures temperature-controlled storage and transportation solutions for vaccines and medical products. Originally founded in 1978 as Brooks Automation, the company rebranded as Azenta in 2021 and completed the divestiture of its legacy semiconductor automation business in 2022. Today, Azenta serves a global customer base of pharmaceutical companies, biotech firms, and healthcare institutions from its operations across North America, Europe, and Asia.
